Treatment of Femoropopliteal Artery In-stent Restenosis

Wonho Kim; Donghoon Choi

doi:10.4070/kcj.2018.0074

Treatment of Femoropopliteal Artery In-stent Restenosis

Korean Circ J. 2018 Mar;48(3):191-197. doi: 10.4070/kcj.2018.0074.

Authors

Wonho Kim¹, Donghoon Choi²

Affiliations

¹ Division of Cardiology, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea.
² Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea. cdhlyj@yuhs.ac.

Abstract

Femoropopliteal (FP) artery-in stent restenosis (ISR) is a daunting management problem that we continue to face. FP artery-ISR rates after primary stent implantation are relatively high. Although repeat FP artery-ISR and the need for additional interventions remain all too common, little consensus exists regarding the best treatment algorithm. In this article, we review the limitations of the currently used devices for the endovascular treatment of FP artery-ISR and discuss which strategies are the most effective and safe.

Keywords: Peripheral artery disease.

Publication types

Review